Bio-Rad Laboratories Class A

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics.

CEO

Norman D. Schwartz

CEONorman D. Schwartz

Employees

7,450

Employees7,450

Headquarters

Hercules, California

HeadquartersHercules, California

Founded

1952

Founded1952

Employees

7,450

Employees7,450

BIO Key Statistics

Market cap

9.32B

Market cap9.32B

Price-Earnings ratio

55.10

Price-Earnings ratio55.10

Dividend yield

—

Dividend yield—

Average volume

348.83K

Average volume348.83K

High today

$352.63

High today$352.63

Low today

$329.60

Low today$329.60

Open price

$329.60

Open price$329.60

Volume

515.67K

Volume515.67K

52 Week high

$352.63

52 Week high$352.63

52 Week low

$236.73

52 Week low$236.73

Stock Snapshot

Bio-Rad Laboratories Class A(BIO) stock is priced at $347.86, giving the company a market capitalization of 9.32B. It carries a P/E multiple of 55.10.

During the trading session on 2026-08-06, Bio-Rad Laboratories Class A(BIO) shares reached a daily high of $352.63 and a low of $329.60. At a current price of $347.86, the stock is +5.5% higher than the low and still -1.4% under the high.

Trading activity shows a volume of 515.67K, compared to an average daily volume of 348.83K.

Over the past 52 weeks, Bio-Rad Laboratories Class A(BIO) stock has traded between a high of $352.63 and a low of $236.73.

BIO News

Simply Wall St 7h

Bio Rad Laboratories Stock Jumps As ddPCR Progress Meets Flat Demand

Bio-Rad Laboratories stock jumped about 4.5% in regular trading, which indicates that traders responded positively to the latest results. The bigger story is le...

Investing.com 1d

Bio-Rad Q2 2026 slides: earnings beat masks ongoing challenges - Investing.com

...

TipRanks 1d

Bio-Rad Restructuring Plan Announced to Boost Competitiveness

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

43%

of 7 ratings

Buy

28.6%

Hold

42.9%

Sell

28.6%

More BIO News

TipRanks 1d

Bio-Rad reports Q2 adjusted EPS $2.62, consensus $1.75

Reports Q2 revenue $651M, consenesus $623.99M. Norman Schwartz, Bio-Rad’s (BIO) Chairman and Chief Executive Officer, stated: “Second-quarter reported revenue w...

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.